球体
生物加工
基质凝胶
3D生物打印
细胞生物学
细胞外基质
体内
细胞培养
紫杉醇
细胞
人体乳房
组织工程
三维细胞培养
生物医学工程
血管生成
癌症
癌症研究
医学
癌细胞
生物
生物技术
遗传学
作者
Swathi Swaminathan,Qudus Hamid,Wei Sun,Alisa Morss Clyne
出处
期刊:Biofabrication
[IOP Publishing]
日期:2019-01-24
卷期号:11 (2): 025003-025003
被引量:110
标识
DOI:10.1088/1758-5090/aafc49
摘要
3D human cancer models provide a better platform for drug efficacy studies than conventional 2D culture, since they recapitulate important aspects of the in vivo microenvironment. While biofabrication has advanced model creation, bioprinting generally involves extruding individual cells in a bioink and then waiting for these cells to self-assemble into a hierarchical 3D tissue. This self-assembly is time consuming and requires complex cellular interactions with other cell types, extracellular matrix components, and growth factors. We therefore investigated if we could directly bioprint pre-formed 3D spheroids in alginate-based bioinks to create a model tissue that could be used almost immediately. Human breast epithelial cell lines were bioprinted as individual cells or as pre-formed spheroids, either in monoculture or co-culture with vascular endothelial cells. While individual breast cells only spontaneously formed spheroids in Matrigel-based bioink, pre-formed breast spheroids maintained their viability, architecture, and function after bioprinting. Bioprinted breast spheroids were more resistant to paclitaxel than individually printed breast cells; however, this effect was abrogated by endothelial cell co-culture. This study shows that 3D cellular structure bioprinting has potential to create tissue models that quickly replicate the tumor microenvironment.
科研通智能强力驱动
Strongly Powered by AbleSci AI